NASDAQ : CTKB
Cytek Biosciences, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 6.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 818.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cytek Biosciences, Inc. (CTKB) reported revenue of 206.71M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 206.71M | 201.49M | 200.45M | 193.01M | 164.04M | 127.95M |
| Cost of Revenue | 99.48M | 97.03M | 89.35M | 83.59M | 63.06M | 48.81M |
| Gross Profit | 107.23M | 104.46M | 111.11M | 109.43M | 100.97M | 79.14M |
| Selling, General & Admin | 117.42M | 108.38M | 92.23M | 93.12M | 67.92M | 45.55M |
| Research & Development | 37.26M | 36.47M | 39.40M | 44.15M | 34.86M | 24.44M |
| Operating Expenses | 154.68M | 144.84M | 131.63M | 137.27M | 102.78M | 69.99M |
| Operating Income | -47.45M | -40.38M | -20.52M | -27.84M | -1.80M | 9.16M |
| Interest Expense | -312.00K | -474.00K | -2.07M | -2.57M | -1.74M | |
| Interest & Investment Income | 2.76M | 2.22M | 10.36M | 6.41M | 4.62M | 49.00K |
| Earnings From Equity Investments | 40.00K | 40.00K | ||||
| Currency Exchange Gain (Loss) | -4.00M | 700.00K | -3.60M | -1.57M | ||
| Other Non Operating Income (Expenses) | 5.39M | 8.10M | 8.06M | 7.79M | 978.00K | |
| EBT Excluding Unusual Items | -43.62M | -29.84M | -5.70M | -15.71M | 1.26M | 5.94M |
| Pretax Income | -40.82M | -29.84M | -5.70M | -15.71M | 1.26M | 5.94M |
| Income Tax Expense | 39.76M | 36.70M | 320.00K | -3.56M | -1.22M | 2.91M |
| Earnings From Continuing Operations | -80.58M | -66.54M | -6.02M | -12.15M | 2.48M | 3.03M |
| Minority Interest in Earnings | 92.00K | 26.00K | ||||
| Net Income | -80.58M | -66.54M | -6.02M | -12.15M | 2.58M | 3.05M |
| Preferred Dividends & Other Adjustments | 3.00M | |||||
| Net Income to Common | -80.58M | -66.54M | -6.02M | -12.15M | 2.58M | 52.00K |
| Shares Outstanding (Basic) | 128.47M | 127.75M | 130.61M | 135.28M | 134.51M | 76.74M |
| Shares Outstanding (Diluted) | 128.47M | 127.75M | 130.61M | 135.28M | 138.56M | 81.54M |
| EPS (Basic) | -0.63 | -0.52 | -0.05 | -0.09 | 0.02 | 0.00 |
| EPS (Diluted) | -0.63 | -0.52 | -0.05 | -0.09 | 0.02 | 0.00 |
| Free Cash Flow | -12.08M | -8.77M | 21.85M | 633.00K | -21.98M | 266.00K |
| Free Cash Flow Per Share | -0.09 | -0.07 | 0.17 | 0.01 | -0.16 | 0.00 |
| Gross Margin | 51.88% | 51.84% | 55.43% | 56.69% | 61.56% | 61.86% |
| Operating Margin | -22.95% | -20.04% | -10.24% | -14.43% | -1.10% | 7.16% |
| Profit Margin | -38.98% | -33.02% | -3.00% | -6.29% | 1.57% | 0.04% |
| Free Cash Flow Margin | -5.84% | -4.35% | 10.90% | 0.33% | -13.40% | 0.21% |
| EBITDA | -39.76M | -32.80M | -13.31M | -21.80M | 688.00K | 10.40M |
| EBITDA Margin | -19.23% | -16.28% | -6.64% | -11.29% | 0.42% | 8.13% |
| D&A For EBITDA | 7.69M | 7.58M | 7.21M | 6.05M | 2.49M | 1.24M |
| EBIT | -47.45M | -40.38M | -20.52M | -27.84M | -1.80M | 9.16M |
| EBIT Margin | -22.95% | -20.04% | -10.24% | -14.43% | -1.10% | 7.16% |
| Effective Tax Rate | 49.02% | |||||
| Revenue as Reported | 206.71M | 201.49M | 200.45M | 193.01M | 164.04M | 127.95M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 73.85M | 90.85M | 98.72M | 167.30M | 296.60M | 364.62M |
| Short-Term Investments | 188.16M | 170.68M | 179.15M | 95.11M | 44.55M | |
| Cash & Short-Term Investments | 262.00M | 261.53M | 277.86M | 262.41M | 341.15M | 364.62M |
| Accounts Receivable | 49.70M | 62.51M | 60.59M | 55.93M | 48.86M | 29.76M |
| Other Receivables | 1.60M | 9.62M | 192.00K | 2.01M | -127.00K | |
| Receivables | 51.30M | 72.13M | 60.59M | 56.12M | 50.88M | 29.63M |
| Inventory | 53.11M | 48.66M | 44.01M | 61.17M | 48.77M | 32.57M |
| Prepaid Expenses | 3.25M | 6.89M | 6.58M | 3.99M | 4.45M | 4.21M |
| Restricted Cash | 29.00K | 331.00K | 2.90M | |||
| Other Current Assets | 8.27M | 2.79M | 7.38M | 8.04M | 5.88M | 708.00K |
| Total Current Assets | 377.93M | 392.00M | 396.45M | 392.06M | 454.02M | 431.73M |
| Property, Plant & Equipment | 31.76M | 29.32M | 28.13M | 29.26M | 27.57M | 5.85M |
| Long-Term Investments | 1.60M | |||||
| Goodwill | 16.69M | 16.70M | 16.66M | 16.18M | 10.14M | 10.14M |
| Other Intangible Assets | 14.87M | 16.82M | 20.13M | 23.08M | 4.33M | 4.74M |
| Long-Term Deferred Tax Assets | 33.37M | 30.49M | 20.46M | 9.17M | ||
| Other Long-Term Assets | 5.68M | 5.10M | 4.76M | 3.38M | 2.96M | 1.67M |
| Total Assets | 446.93M | 461.54M | 499.50M | 494.46M | 519.48M | 463.31M |
| Accounts Payable | 8.41M | 6.41M | 5.53M | 3.03M | 4.80M | 3.03M |
| Accrued Expenses | 25.43M | 25.18M | 21.69M | 18.99M | 20.42M | 14.89M |
| Short-Term Debt | 8.83M | 5.70M | ||||
| Current Portion of Long-Term Debt | 600.00K | 600.00K | 4.66M | 565.00K | 580.00K | |
| Current Portion of Leases | 3.27M | 2.88M | 3.76M | 2.44M | 2.93M | |
| Current Income Taxes Payable | 3.35M | 3.07M | 1.52M | 1.30M | 246.00K | 2.48M |
| Current Unearned Revenue | 30.32M | 29.57M | 26.61M | 24.13M | 14.54M | 8.10M |
| Other Current Liabilities | 4.13M | 4.40M | 3.90M | 5.76M | 5.52M | 4.68M |
| Total Current Liabilities | 84.33M | 77.80M | 67.66M | 56.23M | 49.04M | 33.18M |
| Long-Term Debt | 246.00K | 525.00K | 1.05M | 1.65M | 2.27M | |
| Long-Term Leases | 13.52M | 14.04M | 7.55M | 9.48M | 12.31M | |
| Long-Term Unearned Revenue | 18.06M | 18.34M | 16.10M | 15.13M | 13.12M | 9.79M |
| Other Long-Term Liabilities | 8.82M | 9.09M | 11.40M | 18.91M | 17.18M | 14.95M |
| Total Liabilities | 124.98M | 119.80M | 103.76M | 101.39M | 93.93M | 57.92M |
| Common Stock | 130.00K | 129.00K | 129.00K | 131.00K | 135.00K | 126.00K |
| Additional Paid-In Capital | 451.85M | 441.11M | 430.79M | 423.39M | 442.89M | 423.62M |
| Retained Earnings | -132.76M | -101.74M | -35.20M | -29.18M | -17.03M | -19.61M |
| Comprehensive Income & Other | 2.74M | 2.24M | 16.00K | -1.27M | -697.00K | 897.00K |
| Total Common Equity | 321.95M | 341.74M | 395.74M | 393.06M | 425.30M | 405.04M |
| Minority Interest | 251.00K | 343.00K | ||||
| Shareholders' Equity | 321.95M | 341.74M | 395.74M | 393.06M | 425.55M | 405.38M |
| Total Liabilities & Equity | 446.93M | 461.54M | 499.50M | 494.46M | 519.48M | 463.31M |
| Total Debt | 26.46M | 23.74M | 17.02M | 14.14M | 18.09M | |
| Net Cash (Debt) | 235.54M | 237.79M | 260.85M | 248.27M | 323.06M | 364.62M |
| Net Cash Per Share | 1.83 | 1.86 | 2.00 | 1.84 | 2.33 | 4.47 |
| Filing Date Shares Outstanding | 129.98M | 128.55M | 128.10M | 130.82M | 135.43M | 134.08M |
| Total Common Shares Outstanding | 129.98M | 128.55M | 129.21M | 130.71M | 135.37M | 133.75M |
| Working Capital | 293.60M | 314.19M | 328.78M | 335.83M | 404.98M | 398.55M |
| Book Value Per Share | 2.48 | 2.66 | 3.06 | 3.01 | 3.14 | 3.03 |
| Tangible Book Value | 290.40M | 308.22M | 358.95M | 353.80M | 410.82M | 390.16M |
| Tangible Book Value Per Share | 2.23 | 2.40 | 2.78 | 2.71 | 3.03 | 2.92 |
| Buildings | 8.16M | 7.92M | 7.76M | 7.65M | 5.55M | |
| Machinery | 18.41M | 17.29M | 15.33M | 12.79M | 7.63M | 4.35M |
| Construction In Progress | 1.62M | 1.42M | 357.00K | 256.00K | 178.00K | 344.00K |
| Leasehold Improvements | 6.84M | 3.52M | 3.22M | 3.62M | 3.48M | 3.02M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -80.58M | -66.54M | -6.02M | -12.15M | 2.58M | 3.05M |
| Depreciation & Amortization | 11.90M | 11.97M | 10.49M | 9.23M | 5.66M | 1.24M |
| Loss (Gain) From Sale of Assets | 355.00K | 415.00K | 55.00K | 7.00K | ||
| Asset Writedown & Restructuring Costs | 283.00K | |||||
| Loss (Gain) From Sale of Investments | -5.12M | -5.67M | -5.21M | -6.66M | -77.00K | |
| Loss (Gain) on Equity Investments | -40.00K | |||||
| Stock-Based Compensation | 21.36M | 24.59M | 26.85M | 22.05M | 16.59M | 6.59M |
| Provision & Write-off of Bad Debts | 874.00K | 413.00K | -64.00K | 269.00K | 102.00K | |
| Other Operating Activities | 39.01M | 34.93M | -8.43M | 3.04M | 2.84M | 2.15M |
| Change in Accounts Receivable | 4.88M | 368.00K | -5.43M | -7.33M | -19.74M | -12.37M |
| Change in Inventory | -4.66M | -5.24M | 14.76M | 4.29M | -17.65M | -7.07M |
| Change in Accounts Payable | 1.41M | 448.00K | 2.58M | -1.78M | 1.86M | -256.00K |
| Change in Unearned Revenue | 2.79M | 3.60M | 3.74M | 6.52M | 9.41M | 10.01M |
| Change in Other Net Operating Assets | 1.72M | -3.97M | -7.93M | -12.20M | -13.80M | 1.03M |
| Operating Cash Flow | -6.04M | -4.69M | 25.38M | 5.28M | -12.23M | 4.63M |
| Capital Expenditures | -6.04M | -4.08M | -3.52M | -4.65M | -9.75M | -4.36M |
| Sale of Property, Plant & Equipment | 205.00K | 252.00K | 288.00K | |||
| Cash Acquisitions | -471.00K | -45.13M | -16.63M | |||
| Sale (Purchase) of Intangibles | -91.00K | -106.00K | -204.00K | -179.00K | -120.00K | |
| Investment in Securities | 2.95M | 14.06M | -79.06M | -43.94M | -46.04M | |
| Other Investing Activities | -3.00K | -1.00K | ||||
| Investing Cash Flow | -2.98M | 10.12M | -82.97M | -93.89M | -55.91M | -20.99M |
| Long-Term Debt Issued | 5.58M | 4.18M | 2.98M | |||
| Total Debt Issued | 8.62M | 5.58M | 4.18M | 2.98M | ||
| Short-Term Debt Repaid | -2.77M | |||||
| Long-Term Debt Repaid | -4.75M | -557.00K | -565.00K | -50.00K | ||
| Total Debt Repaid | -5.57M | -4.75M | -557.00K | -565.00K | -50.00K | -2.77M |
| Net Debt Issued (Repaid) | 3.05M | 837.00K | 3.62M | -565.00K | 2.93M | -2.77M |
| Issuance of Common Stock | 1.63M | 1.47M | 2.72M | 3.32M | 2.79M | 216.33M |
| Repurchase of Common Stock | -799.00K | -15.74M | -22.16M | -44.57M | -209.00K | |
| Other Financing Activities | 1.00K | 1.00K | ||||
| Financing Cash Flow | 3.88M | -13.43M | -15.82M | -41.81M | 5.51M | 213.56M |
| Foreign Exchange Rate Adjustments | 3.51M | 109.00K | 4.53M | -1.45M | -2.49M | 1.30M |
| Net Cash Flow | -1.62M | -7.89M | -68.89M | -131.87M | -65.12M | 198.50M |
| Free Cash Flow | -12.08M | -8.77M | 21.85M | 633.00K | -21.98M | 266.00K |
| Free Cash Flow Margin | -5.84% | -4.35% | 10.90% | 0.33% | -13.40% | 0.21% |
| Free Cash Flow Per Share | -0.09 | -0.07 | 0.17 | 0.01 | -0.16 | 0.00 |
| Levered Free Cash Flow | 9.30M | 4.33M | 37.88M | -1.34M | -23.76M | -6.21M |
| Unlevered Free Cash Flow | 9.49M | 4.63M | 37.88M | -43.12K | -22.15M | -5.12M |
| Cash Income Tax Paid | 2.16M | 3.83M | 5.30M | 10.39M | 2.86M | |
| Change in Working Capital | 6.15M | -4.79M | 7.71M | -10.51M | -39.93M | -8.65M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 796.80M | 645.72M | 835.98M | 1.24B | 1.38B | 2.18B |
| Enterprise Value | 561.25M | 408.81M | 572.72M | 963.49M | 1.05B | 1.81B |
| Last Close Price | 6.13 | 5.05 | 6.49 | 9.12 | 10.21 | 16.32 |
| PE Ratio | 534.49 | 41,969.36 | ||||
| Forward PE | 89.56 | 26.14 | 245.06 | 44.39 | 152.95 | |
| PS Ratio | 3.85 | 3.21 | 4.17 | 6.41 | 8.39 | 17.06 |
| PB Ratio | 2.47 | 1.89 | 2.11 | 3.15 | 3.23 | 5.38 |
| P/TBV Ratio | 2.74 | 2.10 | 2.33 | 3.49 | 3.35 | 5.59 |
| P/FCF Ratio | 38.25 | 1,952.94 | 8,204.54 | |||
| P/OCF Ratio | 32.94 | 234.09 | 471.36 | |||
| PEG Ratio | 1.34 | 1.34 | 1.34 | |||
| EV/Sales Ratio | 2.72 | 2.03 | 2.86 | 4.99 | 6.41 | 14.12 |
| EV/EBITDA Ratio | 1,527.81 | 173.67 | ||||
| EV/EBIT Ratio | 197.22 | |||||
| EV/FCF Ratio | 26.21 | 1,522.10 | 6,789.29 | |||
| Debt / Equity Ratio | 0.08 | 0.07 | 0.04 | 0.04 | 0.04 | |
| Debt / EBITDA Ratio | 4.23 | |||||
| Debt / FCF Ratio | 0.78 | 22.33 | ||||
| Net Debt / Equity Ratio | -0.73 | -0.70 | -0.66 | -0.63 | -0.76 | -0.90 |
| Net Debt / EBITDA Ratio | 5.92 | 7.25 | 19.60 | 11.39 | -469.56 | -35.06 |
| Net Debt / FCF Ratio | 19.50 | 27.11 | -11.94 | -392.22 | 14.70 | -1,370.74 |
| Asset Turnover | 0.44 | 0.42 | 0.40 | 0.38 | 0.33 | 0.38 |
| Inventory Turnover | 1.93 | 2.09 | 1.70 | 1.52 | 1.55 | 1.75 |
| Quick Ratio | 3.71 | 4.29 | 5.00 | 5.67 | 7.99 | 11.88 |
| Current Ratio | 4.48 | 5.04 | 5.86 | 6.97 | 9.26 | 13.01 |
| Return on Equity (ROE) | -23.04% | -18.05% | -1.53% | -2.97% | 0.60% | 1.04% |
| Return on Assets (ROA) | -6.31% | -5.25% | -2.58% | -3.43% | -0.23% | 1.68% |
| Return on Invested Capital (ROIC) | -52.92% | -33.82% | -14.68% | -22.52% | -2.52% | 16.50% |
| Return on Capital Employed (ROCE) | -13.10% | -10.50% | -4.80% | -6.40% | -0.40% | 2.10% |
| Earnings Yield | -10.26% | -10.30% | -0.72% | -0.98% | 0.19% | 0.14% |
| FCF Yield | -1.52% | -1.36% | 2.61% | 0.05% | -1.60% | 0.01% |
| Buyback Yield / Dilution | 0.28% | 2.19% | 3.45% | 2.37% | -69.93% | -150.13% |